On August 12, 2026, lucky viewers in and around Greenland, Iceland and Spain—weather allowing—will be able to see one of ...
ECLIPSE registrational program now fully underway, following enrollment of the first patient in ECLIPSE 3 ECLIPSE 3 is designed to compare the combination of tobevibart and elebsiran to bulevirtide in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results